Targeting Sclerostin in Postmenopausal Osteoporosis: Focus on Romosozumab and Blosozumab
Crossref DOI link: https://doi.org/10.1007/s40259-017-0229-2
Published Online: 2017-05-25
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reid, Ian R. http://orcid.org/0000-0001-6021-5458
Funding for this research was provided by:
Health Research Council of New Zealand
License valid from 2017-05-25